참고문헌
- Larson H.E., Price A.B., Honour P. et al. Clostridium difficile and the etiology of pseudomembranous colitis. The Lancet 1978;311(8073):1063-1066. https://doi.org/10.1016/S0140-6736(78)90912-1
- Bartlett J.G. Clostridium difficile: clinical considerations. Rev Infect Dis 1990;12(Suppl 2):S243-51. https://doi.org/10.1093/clinids/12.Supplement_2.S243
- Kelly C.P., Pothoulakis C. and LaMont J.T. Clostridium difficile colitis. N Engl J Med 1994;330(4):257-62. https://doi.org/10.1056/NEJM199401273300406
- Monaghan T., Boswell T. and Mahida Y.R. Recent advances in clostridium difficile- associated disease. Gut 2008;57(6):850-60.
- Cohen S.H., Gerding D.N., Johnson S. et al. Clinical practice guidelines for clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31(5):431-55. https://doi.org/10.1086/651706
- Kelly C.P., LaMont J.T. Clostridium difficile-more difficult than ever. N Engl J Med 2008;359(18):1932-40. https://doi.org/10.1056/NEJMra0707500
- Bartlett J.G. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002;346(5):334-39. https://doi.org/10.1056/NEJMcp011603
- Teasley D.G., Gerding D.N., Olson M.M. et al. Prospective randomised trial of metronidazole 1983;2(8358):1043-46.
- Wenisch C., Parschalk B., Hasenhundl M. et al. Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of clostridium difficile-associated diarrhea. Clin Infect Dis 1996;22(5):813-18. https://doi.org/10.1093/clinids/22.5.813
- Musher D.M., Aslam S., Logan N. et al. Relatively poor outcome after treatment of clostridium difficile colitis with metronidazole. Clin Infect Dis 2005;40(11):1586-90. https://doi.org/10.1086/430311
- Pepin J., Alary M.E., Valiquette L. et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis 2005;40(11):1591-97. https://doi.org/10.1086/430315
- Aslam S., Hamill R.J. and Musher D.M. Treatment of clostridium difficile-associated disease: old therapies and new strategies. Lancet Infect Dis 2005;5(9):549-57. https://doi.org/10.1016/S1473-3099(05)70215-2
- Zar F.A., Bakkanagari S.R., Moorthi K.M. et al. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007;45(3):302-7. https://doi.org/10.1086/519265
- Hookman P., Barkin J.S. Clostridium difficile associated infection, diarrhea and colitis. World J Gastroenterol 2009;15(13):1554-80. https://doi.org/10.3748/wjg.15.1554
- Yoo-jung Choi Y.-s.C., Hye-sook Lee, Hyang-sook Kim et al. Evaluation of oral vancomycin use for the treatment of clostridium difficile-associated disease and risk factor analysis of treatment failure. J. Kor. Soc. Health-Syst. Pharm 2013;30(3):194-201.
- Korea pharmaceutical information Center. Drug information. Available from http://drug.mfds.go.kr/html.indes.jsp. Accessed March 23, 2017.
- Korea pharmaceutical information Center. Drug information. Available from http://drug.mfds.go.kr/html/bxsSearchDrugProduct.jsp?item_Seq=199801540. Accessed March 23, 2017.
- Al-Nassir W.N., Sethi A.K., Nerandzic M.M. et al. Comparison of clinical and microbiological response to treatment of clostridium difficile-associated disease with metronidazole and vancomycin. Clin Infect Dis 2008;47(1):56-62. https://doi.org/10.1086/588293
- Clements A.C., Magalhaes R.J., Tatem A.J. et al. Clostridium difficile PCR ribotype 027:assessing the risks of further worldwide spread. Lancet Infect Dis 2010;10(6):395-404. https://doi.org/10.1016/S1473-3099(10)70080-3
- Lee Y.J., Choi M.G., Lim C.H. et al. Change of clostridium difficile colitis during recent 10 years in Korea. Korean J Gastroenterol 2010;55(3):169-74. https://doi.org/10.4166/kjg.2010.55.3.169
- Loo V.G., Poirier L., Miller M.A. et al. A predominantly clonal multiinstitutional outbreak of clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353(23):2442-449. https://doi.org/10.1056/NEJMoa051639
- Yip C., Loeb M., Salama S. et al. Quinolone use as a risk factor for nosocomial clostridium difficile-associated diarrhea. Infect Control Hosp Epidemiol 2001;22(9):572-75. https://doi.org/10.1086/501954